Total Payments
$193,026
2024 Payments
$24,380
Companies
28
Transactions
614
Payment Breakdown by Category
Other$140,120 (72.6%)
Travel$27,730 (14.4%)
Consulting$13,100 (6.8%)
Food & Beverage$12,076 (6.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $132,560 | 115 | 68.7% |
| Travel and Lodging | $27,730 | 141 | 14.4% |
| Consulting Fee | $13,100 | 10 | 6.8% |
| Food and Beverage | $12,076 | 343 | 6.3% |
| Honoraria | $7,560 | 5 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $141,066 | 319 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $23,602 | 53 | $0 (2019) |
| HNM TOTAL RECON | $8,539 | 7 | $0 (2021) |
| Horizon Pharma plc | $7,019 | 79 | $0 (2018) |
| Medimetriks Pharmaceuticals, Inc. | $6,302 | 47 | $0 (2022) |
| Horizon Therapeutics plc | $3,334 | 41 | $0 (2020) |
| HNM Stainless, LLC | $898.33 | 3 | $0 (2024) |
| Cardiovascular Systems Inc. | $374.96 | 3 | $0 (2017) |
| ANI Pharmaceuticals, Inc. | $350.00 | 1 | $0 (2023) |
| Stryker Corporation | $230.86 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24,380 | 53 | ABBVIE INC. ($24,013) |
| 2023 | $28,967 | 78 | ABBVIE INC. ($28,301) |
| 2022 | $77,204 | 189 | ABBVIE INC. ($75,934) |
| 2021 | $16,580 | 46 | AbbVie Inc. ($12,819) |
| 2020 | $477.08 | 9 | Medimetriks Pharmaceuticals, Inc. ($366.44) |
| 2019 | $27,390 | 105 | Merck Sharp & Dohme Corporation ($23,602) |
| 2018 | $7,925 | 80 | Horizon Pharma plc ($6,838) |
| 2017 | $10,103 | 54 | HNM TOTAL RECON ($8,201) |
All Payment Transactions
614 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | DePuy Synthes Sales Inc. | — | Food and Beverage | In-kind items and services | $25.48 | General |
| 12/10/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/13/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,450.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/13/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $525.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/23/2024 | ABBVIE INC. | DALVANCE (Drug) | Travel and Lodging | In-kind items and services | $656.49 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/23/2024 | ABBVIE INC. | DALVANCE (Drug) | Travel and Lodging | In-kind items and services | $299.03 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/23/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/22/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,450.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/16/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,450.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/16/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,450.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/23/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/18/2024 | ABBVIE INC. | DALVANCE (Drug) | Travel and Lodging | In-kind items and services | $500.53 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/18/2024 | ABBVIE INC. | DALVANCE (Drug) | Travel and Lodging | In-kind items and services | $215.90 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/18/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/16/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $17.95 | General |
| 09/12/2024 | ABBVIE INC. | DALVANCE (Drug) | Travel and Lodging | In-kind items and services | $691.68 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/12/2024 | ABBVIE INC. | DALVANCE (Drug) | Travel and Lodging | In-kind items and services | $350.10 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/12/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $125.02 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/12/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/22/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/08/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $20.12 | General |
| 08/06/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $525.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/06/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $525.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/16/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,450.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/15/2024 | Organogenesis Inc. | PURAPLY WOUND MATRIX (Device) | Food and Beverage | In-kind items and services | $121.25 | General |
| Category: WOUND CARE | ||||||
About Dr. David Mai, D.P.M
Dr. David Mai, D.P.M is a Foot & Ankle Surgery healthcare provider based in Miami Lakes, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/05/2010. The National Provider Identifier (NPI) number assigned to this provider is 1972826808.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Mai, D.P.M has received a total of $193,026 in payments from pharmaceutical and medical device companies, with $24,380 received in 2024. These payments were reported across 614 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($132,560).
Ad
Practice Information
- Specialty Foot & Ankle Surgery
- Location Miami Lakes, FL
- Active Since 03/05/2010
- Last Updated 04/08/2014
- Taxonomy Code 213ES0103X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1972826808
Products in Payments
- DALVANCE (Drug) $140,906
- SIVEXTRO (Drug) $23,602
- RAYOS (Drug) $5,842
- Neo-Synalar (Drug) $3,043
- PRIMARY CARE - DISEASE STATE (Drug) $2,895
- Ketodan (Drug) $1,050
- PENNSAID 2 DICLOFENAC SODIUM TOPICAL SOLUTION (Drug) $944.76
- Loprox Cream (Drug) $648.98
- Clodan Shampoo (Drug) $583.45
- Clindacin P (Drug) $470.18
- Peripheral Orbital Atherectomy System (Device) $374.96
- Veregen (Drug) $350.00
- NO_PRODUCT (Drug) $259.46
- SEGLENTIS (Drug) $213.35
- PENNSAID (Drug) $152.44
- TEFLARO (Drug) $149.55
- DUEXIS (Drug) $138.61
- CoLink (Device) $121.33
- PURAPLY WOUND MATRIX (Device) $121.25
- VIMOVO (Drug) $120.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.